Decheng Capital’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-56,350
Closed -$1.88M 30
2024
Q3
$1.88M Buy
+56,350
New +$1.94M 0.44% 20

Decheng Capital's LBPH Position: Q4 2024 in Review

Decheng Capital sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 56,350 shares — an estimated $1.88M sold.

Decheng Capital first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $1.88M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Decheng Capital reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Decheng Capital sold 56,350 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.88M.
  • Decheng Capital first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Decheng Capital's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.88M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Decheng Capital's 13F filing for Q4 2024, filed 14 Feb 2025.